Spotlight on the transglutaminase 2-heparan sulfate interaction

Furini, G. and Verderio, E.A.M. ORCID: 0000-0001-9153-8997, 2019. Spotlight on the transglutaminase 2-heparan sulfate interaction. Medical Sciences, 7 (1), p. 5. ISSN 2076-3271

[img]
Preview
Text
13165_Verderio.pdf - Published version

Download (2MB) | Preview

Abstract

Heparan sulfate proteoglycans (HSPGs), syndecan-4 (Sdc4) especially, have been suggested as potential partners of transglutaminase-2 (TG2) in kidney and cardiac fibrosis, metastatic cancer, neurodegeneration and coeliac disease. The proposed role for HSPGs in the trafficking of TG2 at the cell surface and in the extracellular matrix (ECM) has been linked to the fibrogenic action of TG2 in experimental models of kidney fibrosis. As the TG2-HSPG interaction is largely mediated by the heparan sulfate (HS) chains of proteoglycans, in the past few years a number of studies have investigated the affinity of TG2 for HS, and the TG2 heparin binding site has been mapped with alternative outlooks. In this review, we aim to provide a compendium of the main literature available on the interaction of TG2 with HS, with reference to the pathological processes in which extracellular TG2 plays a role.

Item Type: Journal article
Publication Title: Medical Sciences
Creators: Furini, G. and Verderio, E.A.M.
Publisher: MDPI AG
Date: 2019
Volume: 7
Number: 1
ISSN: 2076-3271
Identifiers:
NumberType
10.3390/medsci7010005DOI
medsci7010005Publisher Item Identifier
Divisions: Schools > School of Science and Technology
Depositing User: Linda Sullivan
Date Added: 18 Jan 2019 10:27
Last Modified: 18 Jan 2019 10:27
URI: http://irep.ntu.ac.uk/id/eprint/35610

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year